Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Neurol ; 15(1): 66-72, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18042239

RESUMEN

The objective of this multinational open-label, prospective study was to collect, under naturalistic conditions, data on the effectiveness and tolerability of first-line monotherapy with valproate in subjects newly or recently diagnosed with focal onset epilepsy. Patients were treated with sustained release sodium valproate. Seizure control and occurrence of adverse events were assessed after 6 months. Around 1192 adults and 792 children were included. The mean daily valproate dose was 683 mg in children and 987 mg in adults. The retention rate at 6 months was 90.0%. At this time, 77% of subjects were seizure free (83.7% of children and 72.7% of adults). Adverse events possibly related to treatment were observed in 10.2% of subjects, leading to treatment modification for 1.7%. The most common adverse events were weight gain, gastro-intestinal, neurological and skin disorders. Sustained release sodium valproate is effective and shows acceptable tolerability as first-line monotherapy in focal onset epilepsy.


Asunto(s)
Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/efectos adversos , Epilepsias Parciales/tratamiento farmacológico , Ácido Valproico/administración & dosificación , Ácido Valproico/efectos adversos , Adolescente , Adulto , Factores de Edad , Encefalopatías/inducido químicamente , Niño , Preparaciones de Acción Retardada , Relación Dosis-Respuesta a Droga , Epilepsia/tratamiento farmacológico , Femenino , Enfermedades Gastrointestinales/inducido químicamente , Humanos , Cooperación Internacional , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Enfermedades de la Piel/inducido químicamente , Resultado del Tratamiento , Aumento de Peso/efectos de los fármacos
2.
Cesk Patol ; 37(2): 69-71, 2001 Apr.
Artículo en Checo | MEDLINE | ID: mdl-11455917

RESUMEN

An atypical case of congenital myopathy characterised by a low frequency of hypoplastic type 2A fibres, type 2B fibre deficiency and type 1 fibre predominance is reported. Our patients are siblings, a 10 year old girl and a 7 year old boy. Both children suffered from ophthalmoplegia and muscle weakness, and the boy also showed signs of psychomotoric retardation. A muscle biopsy from musculus trapezius has shown type 1 fibre predominance and hypoplastic type 2 fibres.


Asunto(s)
Fibras Musculares de Contracción Rápida/patología , Miopatías Estructurales Congénitas/patología , Niño , Femenino , Humanos , Masculino , Miopatías Estructurales Congénitas/diagnóstico , Miopatías Estructurales Congénitas/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...